Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Cash & Equivalents: 2022-2024

Historic Cash & Equivalents for Praxis Precision Medicines (PRAX) over the last 3 years, with Dec 2024 value amounting to $215.4 million.

  • Praxis Precision Medicines' Cash & Equivalents fell 11.34% to $149.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.5 million, marking a year-over-year decrease of 11.34%. This contributed to the annual value of $215.4 million for FY2024, which is 164.91% up from last year.
  • Praxis Precision Medicines' Cash & Equivalents amounted to $215.4 million in FY2024, which was up 164.91% from $81.3 million recorded in FY2023.
  • In the past 5 years, Praxis Precision Medicines' Cash & Equivalents ranged from a high of $215.4 million in FY2024 and a low of $61.6 million during FY2022.
  • Over the past 3 years, Praxis Precision Medicines' median Cash & Equivalents value was $81.3 million (recorded in 2023), while the average stood at $119.4 million.
  • Data for Praxis Precision Medicines' Cash & Equivalents shows a peak YoY surged of 164.91% (in 2024) over the last 5 years.
  • Praxis Precision Medicines' Cash & Equivalents (Yearly) stood at $61.6 million in 2022, then spiked by 31.95% to $81.3 million in 2023, then surged by 164.91% to $215.4 million in 2024.